John B Harley Selected Research

Heterophile Antibodies

1/2022

A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John B Harley Research Topics

Disease

74	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 08/2002
21	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2002
8	Inflammation (Inflammations) 02/2021 - 03/2008
7	Lupus Nephritis 02/2021 - 04/2009
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 09/2011
5	Rheumatoid Arthritis 04/2019 - 08/2003
4	Epstein-Barr Virus Infections 01/2022 - 01/2006
4	Infections 09/2014 - 01/2006
4	Arthritis (Polyarthritis) 02/2011 - 05/2002
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 03/2011
3	Multiple Sclerosis 01/2020 - 09/2007
3	Proteinuria 01/2016 - 01/2011
3	malar rash 01/2012 - 01/2011
3	Nephritis 04/2009 - 02/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 01/2018
2	Eosinophilic Esophagitis 01/2018 - 11/2014
2	Asthma (Bronchial Asthma) 02/2017 - 10/2011
2	Vitamin D Deficiency 01/2017 - 09/2011
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2016 - 12/2014
2	Measles 09/2014 - 08/2004
2	Mumps 09/2014 - 08/2004
2	Disease Susceptibility (Diathesis) 06/2013 - 08/2007
2	Lymphopenia (Lymphocytopenia) 01/2013 - 01/2012
2	Muscular Diseases (Myopathy) 10/2011 - 09/2011
2	Oral Ulcer (Mouth Ulcer) 10/2011 - 02/2011
2	Inhalation anthrax 05/2011 - 07/2010
2	Anthrax 05/2011 - 07/2010
1	Premature Birth (Birth, Premature) 12/2021
1	COVID-19 related pediatric multisystem inflammatory disease 09/2021
1	Cataract (Cataracts) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Bronchiolitis Obliterans Syndrome 10/2017
1	Airway Remodeling 02/2017

Drug/Important Bio-Agent (IBA)

29	AutoantibodiesIBA 01/2022 - 04/2003
14	AntibodiesIBA 01/2022 - 05/2002
9	AutoantigensIBA 01/2022 - 04/2003
9	InterferonsIBA 01/2020 - 06/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2003
7	AntigensIBA 02/2021 - 08/2004
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2003
5	Immunoglobulin G (IgG)IBA 01/2022 - 06/2003
5	EBV-encoded nuclear antigen 1IBA 01/2020 - 06/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 03/2006
4	Antigen-Antibody Complex (Immune Complex)IBA 02/2021 - 12/2007
4	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 07/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 08/2003
4	Interferon Type IIBA 11/2016 - 01/2010
4	CytokinesIBA 01/2016 - 12/2011
3	Biological ProductsIBA 01/2022 - 09/2012
3	EpitopesIBA 01/2022 - 05/2002
3	MicroRNAs (MicroRNA)IBA 01/2016 - 05/2010
3	Interleukin-2 (IL2)IBA 11/2012 - 06/2011
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
2	ChromatinIBA 01/2022 - 11/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 02/2009
2	ORALIT (ORS)IBA 01/2020 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2010
2	hydroxide ionIBA 01/2017 - 09/2011
2	Vitamin D FDA LinkGeneric 01/2017 - 09/2011
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2016 - 09/2004
2	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 12/2014 - 08/2007
2	VaccinesIBA 09/2014 - 07/2010
2	Toll-Like Receptor 7IBA 01/2013 - 09/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 11/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011 - 09/2011
2	Antinuclear AntibodiesIBA 09/2011 - 09/2004
2	anti-dsDNA autoantibodyIBA 03/2011 - 01/2011
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2011 - 06/2010
2	CD11b AntigenIBA 03/2009 - 02/2008
2	Antiphospholipid AntibodiesIBA 04/2004 - 02/2003
1	Heterophile AntibodiesIBA 01/2022
1	Complement 3d Receptors (Complement Receptor 2)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 12/2021
1	moesinIBA 02/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Intergenic DNA (Junk DNA)IBA 01/2021
1	ElementsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	LipidsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2020
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2019
1	Cardiolipins (Cardiolipin)IBA 04/2019
1	nasIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Prostaglandin-E SynthasesIBA 02/2017
1	Dinoprostone (PGE2)FDA Link 02/2017
1	Vitamin D3 24-HydroxylaseIBA 01/2017

Therapy/Procedure

4	Therapeutics 09/2021 - 01/2011
2	Immunotherapy 01/2015 - 08/2012